KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 139 filers reported holding KRYSTAL BIOTECH INC in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,554 | -1.2% | 185,809 | 0.0% | 0.29% | +4.3% |
| Q2 2023 | $21,814 | +20.7% | 185,809 | -17.7% | 0.28% | +13.7% |
| Q1 2023 | $18,078 | +1.1% | 225,809 | 0.0% | 0.25% | +4.6% |
| Q4 2022 | $17,889 | -99.9% | 225,809 | 0.0% | 0.24% | +9.2% |
| Q3 2022 | $15,739,000 | +6.2% | 225,809 | 0.0% | 0.22% | +16.7% |
| Q2 2022 | $14,827,000 | -1.3% | 225,809 | 0.0% | 0.19% | +13.4% |
| Q1 2022 | $15,025,000 | +15.6% | 225,809 | +21.5% | 0.16% | +33.3% |
| Q4 2021 | $12,997,000 | +34.0% | 185,809 | 0.0% | 0.12% | +23.0% |
| Q3 2021 | $9,701,000 | -23.2% | 185,809 | 0.0% | 0.10% | -23.1% |
| Q2 2021 | $12,635,000 | -11.7% | 185,809 | 0.0% | 0.13% | -7.1% |
| Q1 2021 | $14,315,000 | +28.4% | 185,809 | 0.0% | 0.14% | +25.0% |
| Q4 2020 | $11,149,000 | +39.4% | 185,809 | 0.0% | 0.11% | +24.4% |
| Q3 2020 | $7,999,000 | +42.2% | 185,809 | +36.8% | 0.09% | +36.4% |
| Q2 2020 | $5,625,000 | -4.2% | 135,809 | 0.0% | 0.07% | -19.5% |
| Q1 2020 | $5,872,000 | – | 135,809 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $53,700,000 | 4.14% |
| S Squared Technology, LLC | 85,215 | $5,113,000 | 2.93% |
| First Light Asset Management, LLC | 491,740 | $29,504,000 | 2.18% |
| Redmile Group, LLC | 1,675,036 | $100,502,000 | 1.22% |
| Nicholas Investment Partners, LP | 233,543 | $14,013,000 | 1.08% |
| HighMark Wealth Management LLC | 17,586 | $1,055,000 | 0.91% |
| DSAM Partners (London) Ltd | 87,608 | $5,256,000 | 0.62% |
| SPHERA FUNDS MANAGEMENT LTD. | 101,044 | $6,063,000 | 0.54% |
| Hood River Capital Management LLC | 261,122 | $15,667,000 | 0.52% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 9,900 | $594,000 | 0.45% |